Decrease in Enteroviral Meningitis: An Unexpected Benefit of Coronavirus Disease 2019 (COVID-19) Mitigation?

Kami D Kies; Amber S Thomas; Matthew J Binnicker; Kelli L Bashynski; Robin Patel

doi:10.1093/cid/ciaa1881

Decrease in Enteroviral Meningitis: An Unexpected Benefit of Coronavirus Disease 2019 (COVID-19) Mitigation?

Clin Infect Dis. 2021 Nov 2;73(9):e2807-e2809. doi: 10.1093/cid/ciaa1881.

Authors

Kami D Kies¹, Amber S Thomas¹, Matthew J Binnicker¹, Kelli L Bashynski¹, Robin Patel^{1

2}

Affiliations

¹ Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
² Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Abstract

Enteroviral meningitis is seasonal, typically exhibiting a rise in prevalence in late summer/early fall. Based on clinical microbiology laboratory testing data of cerebrospinal fluid, the expected August/September/October peak in enteroviral meningitis did not occur in 2020, possibly related to coronavirus disease 2019 (COVID-19) mitigation strategies.

Keywords: COVID-19; PCR; enterovirus; meningitis.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Enterovirus Infections* / epidemiology
Enterovirus Infections* / prevention & control
Enterovirus*
Humans
Infant
Meningitis, Viral* / diagnosis
Meningitis, Viral* / epidemiology
Meningitis, Viral* / prevention & control
SARS-CoV-2

Abstract

Publication types

MeSH terms

Grants and funding